openPR Logo
Press release

Recent FDA Approvals Driving Growth in the Neuroleptic Drugs Market By 2031 | Most Leading Companies - Eli Lily and Company, Johnson and Johnson, Pfizer Inc., AstraZeneca plc, Otsuka Pharmaceutical Co, Ltd

03-28-2025 08:38 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Neuroleptic Drugs Market

Neuroleptic Drugs Market

Neuroleptic Drugs Market size is estimated to reach high at a CAGR of 5.6% during the forecast period (2024-2031).

Neuroleptic Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neuroleptic-drugs-market?kb

Neuroleptic drugs, also known as antipsychotics, are a class of medications primarily used to manage psychotic disorders such as schizophrenia, bipolar disorder, and severe depression. They work by modulating neurotransmitter activity in the brain, particularly dopamine, to reduce symptoms like hallucinations, delusions, and mood disturbances. Neuroleptics are categorized into typical (first-generation) and atypical (second-generation) antipsychotics, with the latter often having fewer side effects.

List of the Key Players in the Neuroleptic Drugs Market:

Eli Lily and Company, Johnson and Johnson, Pfizer Inc., AstraZeneca plc, Otsuka Pharmaceutical Co, Ltd., Sumitomo Dainippon Pharma Co., Ltd., Alkermes plc, H. Lundbeck A/S, Abbvie Inc, Dr. Reddy's Laboratories Ltd

Industry Development:

On January 29, 2019, Sumitomo Dainippon Pharma Co., Ltd. introduced Latuda (lurasidone hydrochloride), an atypical antipsychotic, for the treatment of schizophrenia in China.

Growth Forecast Projected:

The Global Neuroleptic Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Neuroleptic Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/neuroleptic-drugs-market?kb

Segment Covered in the Neuroleptic Drugs Market:

By Drug: First Generation (Typical), Second Generation (Atypical)

By Application: Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Other

By End-User: Hospital Pharmacies, Retail Pharmacies, Other

Regional Analysis for Neuroleptic Drugs Market:

The regional analysis of the Neuroleptic Drugs Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neuroleptic-drugs-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Neuroleptic Drugs market?

➠ Who are the leading manufacturers in the global Neuroleptic Drugs industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Neuroleptic Drugs industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Neuroleptic Drugs market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/neuroleptic-drugs-market

Lamellar Ichthyosis Treatment Market - https://datamintelligence.com/research-report/lamellar-ichthyosis-treatment-market?kb

Checkpoint Inhibitor Refractory Cancer Market - https://datamintelligence.com/research-report/checkpoint-inhibitor-refractory-cancer-market?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recent FDA Approvals Driving Growth in the Neuroleptic Drugs Market By 2031 | Most Leading Companies - Eli Lily and Company, Johnson and Johnson, Pfizer Inc., AstraZeneca plc, Otsuka Pharmaceutical Co, Ltd here

News-ID: 3944027 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Food Tech Market to Grow at 9.9% CAGR, Driven by Digitalization, Sustainability Demands, and Supply Chain Innovation | DataM Intelligence
Food Tech Market to Grow at 9.9% CAGR, Driven by Digitalization, Sustainability …
The global Food Tech Market reached USD 105.28 billion in 2024 and is projected to reach USD 224.31 billion by 2032, growing at a CAGR of 9.9% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Instacart launched an AI-powered meal planning and automated grocery delivery service, integrating with smart kitchen devices. ✅ In October 2025, the FDA approved the first 3D-printed plant-based meat
Colposcopes Market Poised for Robust Global Growth US$ 787.84 Million by 2033 | Leading Companies - Gynex Corporation, Ecleris, Karl Kaps GmbH & Co. KG, Medgyn Products Inc
Colposcopes Market Poised for Robust Global Growth US$ 787.84 Million by 2033 | …
Colposcopes Market size reached US$ 515.23 Million with rise of US$ 536.15 Million in 2024 is expected to reach US$ 787.84 Million by 2033, growing at a CAGR of 4.4% during the forecast period 2025-2033 DataM Intelligence has published a new research report on "Colposcopes Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players
United States Cosmetic CDMO Industry | Global Players Expand Turnkey Capabilities & R&D Hubs - Swiss American, NOX BELLCOW Cosmetics Co., Ltd, COSMOBEAUTY Co., Ltd., BiofarmaSrl, TOA Inc
United States Cosmetic CDMO Industry | Global Players Expand Turnkey Capabilitie …
Cosmetic CDMO Market reached US$ 22.44billion in 2023, with a rise to US$ 23.50 billion in 2024, and is expected to reach US$ 35.79billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Cosmetic CDMO Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of
United States Automotive Intelligence Tires Industry Sector Growth To 2031 | Bridgestone, Continental, MICHELIN, Pirelli
United States Automotive Intelligence Tires Industry Sector Growth To 2031 | Bri …
DataM Intelligence has published a new research report on "Automotive Intelligence Tires Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample PDF Of This

All 5 Releases


More Releases for Neuroleptic

Neuroleptic Malignant Syndrome (NMS) Market Detailed Industry Report Analysis 20 …
Introduction Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening reaction to neuroleptic or antipsychotic drugs, characterized by severe muscle rigidity, hyperthermia, altered mental status, and autonomic dysfunction. Though infrequent, NMS requires rapid diagnosis and intervention to prevent mortality. Its strong association with widely prescribed antipsychotics has made awareness, prevention, and treatment of NMS a critical focus within the healthcare industry. The global NMS market is shaped by ongoing improvements in hospital
Neuroleptic Market Increasing Demand, Growth Analysis and Future Outlook by 2030
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the
Neuroleptic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Neuroleptic Drugs Market Overview: Neuroleptic Drugs Market Witnesses Steady Growth with Anticipated CAGR of 5.6% The global neuroleptic drugs market is poised to witness substantial growth, projecting a Compound Annual Growth Rate (CAGR) of 5.6% throughout the forecast period spanning from 2022 to 2029. Antipsychotics, also recognized as neuroleptics, continue to be at the forefront of psychiatric treatment, notably combating schizophrenia and a spectrum of other psychotic disorders. Market Metrics CAGR: 5.6% Segments Covered: By
Neuroleptic Market Outlook 2029: Presents Market Insights & Depth Analysis
This Neuroleptic Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Neuroleptic Market study report. All this crucial data
Neuroleptic Market Share, Trends, Future Outlook, Analysis and Forecast 2023-203 …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the
Neuroleptic Market Share 2023: Global Trends, Key Players, Industry Analysis and …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the